Chemotherapy in the treatment of cancer of the ovary.

No abstract is available for this paper.

• Publication year

  1971

• Venue

  American Journal of Obstetrics and Gynecology

• Publication date

  1971-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00006254-197102000-00024PMID 4316665
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Disseminated carcinoma of the ovary treated by L‐phenylalanine mustard

  1968cited by this paper

• Tratamento do Câncer Avançado do Ovário. Resultados com o AVC (Adriamicina, VM-26 (Teniposide) e Ciclofosfamida)

  2023cites this paper
• Residual Cancer Stem Cells after Interval Cytoreductive Surgery following Neoadjuvant Chemotherapy Could Result in Poor Treatment Outcomes for Ovarian Cancer

  2010cites this paper
• Chemotherapy of malignant ovarian tumors--therapeutic results with cisplatin.

  2010cites this paper
• Combination chemotherapy for immature (malignant) teratomas of the ovary.

  2010cites this paper
• Combination chemotherapy in malignant non-seminomatous germ-cell tumors: results of a cooperative study of the German Society of Pediatric Oncology (MAKEI 83)

  2004cites this paper
• Clinical data of Granulosa cell tumors

  2004cites this paper
• Management of Germ Cell Tumors in Children: Approaches to Cure

  2002cites this paper
• A Clinical Study of 7 Cases of Ovarian Dysgerminoma

  2001cites this paper
• Cisplatin (P), vinblastine (V) and bleomycin (B) combination chemotherapy in recurrent or advanced granulosa(-theca) cell tumours of the ovary. An EORTC Gynaecological Cancer Cooperative Group study.

  1999cites this paper
• A Phase I trial of intravenous melphalan, paclitaxel, and cisplatin plus granulocyte‐colony stimulating factor in patients with suboptimal advanced epithelial ovarian carcinoma or peritoneal carcinoma

  1999cites this paper
• Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: A Gynecologic Oncology Group study.

  1999cites this paper
• Long-term results in patients with advanced epithelial ovarian carcinoma treated with a combination of cisplatin, doxorubicin, and cyclophosphamide.

  1997cites this paper
• Whole-abdomen radiation therapy as salvage treatment for epithelial ovarian carcinoma.

  1997cites this paper
• Secondary surgical cytoreduction for advanced epithelial ovarian cancer: Patient selection and review of the literature

  1996cites this paper
• Clinical review of adult granulosa cell tumors of the ovary.

  1995cites this paper
• Survival of advanced ovarian cancer patients with microscopic partial response after surgery and first-line chemotherapy.

  1995cites this paper
• A phase I study of intraperitoneal interferon-alpha 2b and intravenous cis-platinum plus cyclophosphamide chemotherapy in patients with untreated stage III epithelial ovarian cancer: a Gynecologic Oncology Group pilot study.

  1995cites this paper
• Chemotherapy of Epithelial Ovarian Cancer: An Overview

  1994cites this paper
• Cis‐platinum/vinblastine/bleomycin combination chemotherapy in advanced or recurrent granulosa cell tumors of the ovary

  1991cites this paper
• Characterization of in vitro chemosensitivity of perioperative human ovarian malignancies by adenosine triphosphate chemosensitivity assay.

  1991cites this paper
• Management of epithelial ovarian neoplasms using a platinum‐based regimen: A 10‐year experience

  1990cites this paper
• Neoadjuvant chemotherapy in stage X ovarian carcinoma.

  1990cites this paper
• Ten-year follow-up of patients receiving cisplatin, doxorubicin, and cyclophosphamide chemotherapy for advanced epithelial ovarian carcinoma.

  1989cites this paper
• Neoadjuvant (Cytoreductive) Chemotherapy Combined With Intervention Debulking Surgery in Advanced, Unresected Epithelial Ovarian Cancer

  1989cites this paper
• Second-look surgery in ovarian carcinoma.

  1988cites this paper
• Update in cancer chemotherapy: genitourinary tract cancer, Part 5: Ovarian cancer.

  1988cites this paper
• Whole abdominal irradiation following chemotherapy in advanced ovarian carcinoma.

  1988cites this paper
• 6-[Bis(2-chloroethyl)amino]-6-deoxygalactopyranose hydrochloride (C6-galactose mustard), a new alkylating agent with reduced bone marrow toxicity.

  1987cites this paper
• Treatment of metastatic stromal tumors of the ovary with cis‐platin, doxorubicin, and cyclophosphamide

  1987cites this paper
• Sequential multi-agent chemotherapy and whole abdominal irradiation for stage III ovarian carcinoma.

  1986cites this paper
• Epithelial ovarian cancer: do all metastases present similar chemosensitivity?

  1986cites this paper
• Chemotherapy of drug-resistant ovarian cancer: a Southwest Oncology Group Study.

  1986cites this paper
• Multimodal approach to the treatment of stage III ovarian carcinoma: preliminary report of a pilot study and critical review.

  1985cites this paper
• A randomized comparison of cyclophosphamide, adriamycin, and 5‐fluorouracil with triethylenethiophosphoramide and methotrexate, both as sequential and as fixed rotational treatment in patients with advanced ovarian cancer

  1985cites this paper
• Preliminary results of the GPO-trial for treatment of non-testicular germ-cell tumors in children and adolescents.

  1985cites this paper
• Cisplatin, methotrexate, and 5-fluorouracil combination chemotherapy for advanced ovarian cancer.

  1985cites this paper
• Single agent vs. combination chemotherapy for ovarian cancer.

  1985cites this paper
• [Prognostic factors of ovarian cancer].

  1985cites this paper
• Second-look laparotomy for ovarian carcinoma.

  1985cites this paper
• Radiotherapeutic management of ovarian cancer.

  1984cites this paper
• [Chemotherapy of advanced epithelial ovarian carcinoma].

  1984cites this paper
• Whole abdominal and pelvic irradiation in patients with minimal disease at second-look surgical reassessment for ovarian carcinoma.

  1984cites this paper
• Management of germ cell and stromal tumors of the ovary.

  1984cites this paper
• The chemotherapy of granulosa cell tumors of the ovary: experience of the Wisconsin Clinical Cancer Center.

  1984cites this paper
• Calcified intraperitoneal and mediastinal implants in malignant ovarian teratoma.

  1984cites this paper
• Treatment of advanced ovarian cancer with combination chemotherapy using cyclophosphamide, adriamycin and cis‐platinum

  1984cites this paper
• Treatment of advanced and recurrent ovarian carcinoma with cyclophosphamide, doxorubicin, and cisplatin

  1984cites this paper
• Comparison of melphalan with cyclophosphamide, methotrexate, and 5‐fluorouracil in patients with ovarian cancer

  1984cites this paper
• Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO Stages III and IV) as measured by surgical end-staging (second-look operation).

  1983cites this paper
• Radiation therapy in the management of ovarian cancer.

  1983cites this paper
• Cis‐platinum plus high‐dose methotrexate Toxicity and efficacy in ovarian carcinoma

  1983cites this paper
• THERAPEUTIC PROGRESS—REVIEW VIII DO THE NEWER CYTOTOXIC DRUGS REPRESENT A SIGNIFICANT ADVANCE IN THE TREATMENT OF CANCER?

  1983cites this paper
• A prospective randomized clinical trial of melphalan and cis-platinum versus hexamethylmelamine, adriamycin, and cyclophosphamide in advanced ovarian cancer.

  1983cites this paper
• The use of intravenous phenylalanine mustard followed by supervoltage irradiation in the treatment of carcinoma of the ovary

  1983cites this paper
• Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO III and IV) as measured by surgical end-staging (second-look surgery)--the mount sinai experience.

  1983cites this paper
• The role of radiotherapy in ovarian cancer.

  1982cites this paper
• FQC combination chemotherapy for primary malignant ovarian tumor.

  1982cites this paper
• [Clinical aspects and therapy in primary ovarian cancer].

  1982cites this paper
• [Advanced epithelial cancers of the ovary: results of 4 chemotherapy protocols (110 cases)].

  1982cites this paper
• Histologic correlates of virulence in ovarian adenocarcinoma. I. Effect of differentiation.

  1982cites this paper
• Effect of cis-diamminedichloroplatinum chemotherapy on the survival of patients with advanced ovarian cancer.

  1981cites this paper
• Improved chemotherapy for ovarian cancer with cis‐diamminedichloroplatinum and adriamycin

  1981cites this paper
• The natural history and treatment of ovarian cancer.

  1981cites this paper
• Epithelial carcinoma of the ovary: current strategies.

  1981cites this paper
• [Simultaneous radio-chemotherapy of advanced epithelial ovarian cancer--results after three years (author's transl)].

  1981cites this paper
• The role of hexamethylmelamine in advanced ovarian carcinoma treatment.

  1981cites this paper
• Randomised trial comparing low-dose cisplatin and chlorambucil with low-dose cisplatin, chlorambucil, and doxorubicin in advanced ovarian carcinoma.

  1981cites this paper
• Current status of therapeutic modalities for treatment of gynecologic malignancies with emphasis on chemotherapy.

  1981cites this paper
• Response to second line chemotherapy in ovarian cancer of epithelial origin.

  1981cites this paper
• [The importance of second-look surgery following radio-chemotherapy for advanced ovarian cancer (author's transl)].

  1980cites this paper
• Chemotherapy of Recurrent Ovarian Carcinoma with cis‐Dichlorodiammine Platinum II and Adriamycin

  1980cites this paper
• Pharmacokinetic approach to in vitro testing of ovarian cancer cell sensitivity.

  1980cites this paper
• Combination chemotherapy in advanced ovarian cancer.

  1980cites this paper
• Combination v. sequential therapy with melphalan, 5-fluorouracil and methotrexate for advanced ovarian cancer.

  1980cites this paper
• Treatment of women with disseminated or recurrent advanced ovarian cancer with melphalan alone in combination with 5‐fluorouracil and dactinomycin or with the combination of cytoxan, 5‐fluorouracil and dactinomycin

  1980cites this paper
• Phase II study of Leo 1031 (prednimustine) in advanced ovarian carcinoma.

  1979cites this paper
• The role of autologous stem cell reconstitution in intensive therapy for resistant neoplasms.

  1979cites this paper
• Granulosa cell tumors of the ovary. A clinicopathological study of 118 cases with long-term follow-up.

  1979cites this paper
• Therapy of advanced ovarian carcinoma.

  1979cites this paper
• Teratomas of the ovary.

  1979cites this paper
• [Monochemotherapeutic treatment of advanced stage III and IV ovarian cancer].

  1979cites this paper
• Chemotherapy in the Management of Ovarian Carcinoma: A Review 1

  1979cites this paper
• Ovarian cancer: diagnosis, staging, treatment.

  1979cites this paper
• Long-term survival in a case of stage IV carcinoma of the ovary treated with a single chemotherapeutic agent.

  1979cites this paper
• Hexa-CAF combination chemotherapy and other multiple-drug regimens in advanced ovarian carcinoma: present and future.

  1979cites this paper
• Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy.

  1978cites this paper
• Delayed recurrence and chemotherapy of a granulosa cell tumor.

  1978cites this paper
• A temporary response of recurrent granulosa cell tumor to adriamycin.

  1978cites this paper
• Chemotherapy of ovarian cancer.

  1978cites this paper
• Melphalan chemotherapy in advanced ovarian carcinoma.

  1978cites this paper
• Chemotherapy in ovarian carcinoma recurrent after radiation therapy.

  1978cites this paper
• Adriamycin in ovarian cancer patients resistant to cyclophosphamide.

  1978cites this paper
• [Combination of adriamycin and cis-diammine-dichloro-platinum (II) in the treatment of advanced, therapy-resistant, ovarian carcinoma (author's transl)].

  1978cites this paper
• Stage III ovarian carcinoma: treatment and results. Comparison of multiple drugs, a single drug, and irradiation.

  1977cites this paper
• Second trial drugs in ovarian cancer.

  1977cites this paper
• Intravenous corynebacterium parvum. An adjunct to chemotherapy for resistant advanced ovarian cancer

  1977cites this paper
• Treatment of intraperitoneal implants in mice using 32P or 60Co.

  1977cites this paper
• Chemotherapeutic Retroconversion of Immature Teratoma of the Ovary

  1977cites this paper
• Melphalan vs polymelphalanum in ovarian cancer patients resistant to cyclophosphamide: a tentative statistical approach to balance risks and benefits.

  1977cites this paper
• A Phase II Study of Combined Adriamycin, L-PAM, and Methotrexate with Citrovorum Factor Rescue in Advanced Ovarian Carcinomas

  1977cites this paper